van der Laan M - Search Results

1

The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.

Rosenblum M, Deeks SG, van der Laan M, Bangsberg DR. Rosenblum M, et al. Among authors: van der laan m. PLoS One. 2009 Sep 29;4(9):e7196. doi: 10.1371/journal.pone.0007196. PLoS One. 2009. PMID: 19787058 Free PMC article.

2

Assessing the effectiveness of antiretroviral adherence interventions. Using marginal structural models to replicate the findings of randomized controlled trials.

Petersen ML, Wang Y, van der Laan MJ, Bangsberg DR. Petersen ML, et al. J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S96-S103. doi: 10.1097/01.qai.0000248344.95135.8d. J Acquir Immune Defic Syndr. 2006. PMID: 17133209

3

Individualized treatment rules: generating candidate clinical trials.

Petersen ML, Deeks SG, van der Laan MJ. Petersen ML, et al. Stat Med. 2007 Nov 10;26(25):4578-601. doi: 10.1002/sim.2888. Stat Med. 2007. PMID: 17450501 Free PMC article.

4

Virologic efficacy of boosted double versus boosted single protease inhibitor therapy.

Petersen ML, Wang Y, van der Laan MJ, Rhee SY, Shafer RW, Fessel WJ. Petersen ML, et al. AIDS. 2007 Jul 31;21(12):1547-54. doi: 10.1097/QAD.0b013e32825a69a8. AIDS. 2007. PMID: 17630549 Free PMC article.

5

Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.

Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, van der Laan M, Jewell N, McIntyre J; MIRA Team. Padian NS, et al. Among authors: van der laan m, van der straten a. Lancet. 2007 Jul 21;370(9583):251-261. doi: 10.1016/S0140-6736(07)60950-7. Lancet. 2007. PMID: 17631387 Free PMC article. Clinical Trial.

6

Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis.

Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Petersen ML, et al. Clin Infect Dis. 2007 Oct 1;45(7):908-15. doi: 10.1086/521250. Epub 2007 Aug 20. Clin Infect Dis. 2007. PMID: 17806060 Free PMC article.

7

History-adjusted marginal structural models for estimating time-varying effect modification.

Petersen ML, Deeks SG, Martin JN, van der Laan MJ. Petersen ML, et al. Am J Epidemiol. 2007 Nov 1;166(9):985-93. doi: 10.1093/aje/kwm232. Epub 2007 Sep 17. Am J Epidemiol. 2007. PMID: 17875580 Free PMC article.

8

Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification.

Petersen ML, van der Laan MJ, Napravnik S, Eron JJ, Moore RD, Deeks SG. Petersen ML, et al. AIDS. 2008 Oct 18;22(16):2097-106. doi: 10.1097/QAD.0b013e32830f97e2. AIDS. 2008. PMID: 18832873 Free PMC article.

9

Using regression models to analyze randomized trials: asymptotically valid hypothesis tests despite incorrectly specified models.

Rosenblum M, van der Laan MJ. Rosenblum M, et al. Among authors: van der laan mj. Biometrics. 2009 Sep;65(3):937-45. doi: 10.1111/j.1541-0420.2008.01177.x. Epub 2009 Feb 4. Biometrics. 2009. PMID: 19210739 Free PMC article.

10

Simple, efficient estimators of treatment effects in randomized trials using generalized linear models to leverage baseline variables.

Rosenblum M, van der Laan MJ. Rosenblum M, et al. Among authors: van der laan mj. Int J Biostat. 2010 Apr 1;6(1):Article 13. doi: 10.2202/1557-4679.1138. Int J Biostat. 2010. PMID: 20628636 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

499 results

Search Page